As a sales rep for drug manufacturers Questcor, Lisa Pratta always suspected the company's business practices weren't just immoral but illegal, too, as she explains in "False Claims One Insider's Impossible Battle Against Big Pharma Corruption." Pratta began working for Questcor in 2010 as the sales rep in the Northeast region for Acthar, a drug which helped relieve autoimmune and inflammatory disorders. "If prescribed correctly, Acthar could help people walk again. And talk again," writes Pratta. But, she adds, "Questcor made more money when it was prescribed incorrectly." They would do anything to sell Acthar. From paying doctors to prescribe it to using bogus research studies proclaiming its miraculous efficacy, they were so successful that Achtar's price rose from $40 per vial in 2000 to nearly $39,000 in 2019 " an increase of 97,000%. Some sales reps were making up to $4 million a year and, in turn, kept the physicians doing their bidding in a life of luxury. "They took them on scuba diving trips and bought clothes and shoes for their wives. One guy bought his doctor a brand new Armani suit and expensed it to Questcor," she recalls. In March 2019, the Department of Justice served a 100-page lawsuit against Mallinckrodt, alleging illegal marketing of Acthar, bribing doctors to boost sales and defrauding government health care programs. It also mentioned Pratta's role in the case, meaning her long-held anonymity was now public knowledge.